Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolent Health, Inc.EVH · Entity 5492 | Chief Financial Officer | July 01, 2025 | July 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolent Health, Inc.
Report date July 01, 2025 · Filed July 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 309,245 |
Reported balance
After 2025-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-07-01 · Grant · Acquired 25,461 · Balance 309,245 F1: Represents restricted stock units granted to Mr. Johnson pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028. F3: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting. F4: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Mr. Johnson pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028.
F3: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting.
F4: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2025 Filed Jul 3, 2025 11:06 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 25,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000100 · wk-form4_1751540772.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,245 F1 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028. F3 · shares: Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting. F4 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 26,872 | $8.77 | $235,667.44 |
DisclosureSEC source: 0001628908-25-000022 · wk-form4_1741129767.xml · nonDerivative · entry 4 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,784 F6 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 59,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000022 · wk-form4_1741129767.xml · nonDerivative · entry 3 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,656 F5 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 89,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000022 · wk-form4_1741129767.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,074 F3 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F4 · shares: Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 9,246 | $8.99 | $83,121.54 |
DisclosureSEC source: 0001628908-25-000022 · wk-form4_1741129767.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,961 F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:11 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 44,693 | $30.00 | $1,340,790.00 |
DisclosureSEC source: 0001628908-24-000094 · wk-form4_1724717458.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,207 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 02, 2024 Filed Mar 6, 2024 00:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 9,020 | $34.41 | $310,378.20 |
DisclosureSEC source: 0001628908-24-000034 · wk-form4_1709683768.xml · nonDerivative · entry 3 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,900 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 11,213 | $34.41 | $385,839.33 |
DisclosureSEC source: 0001628908-24-000034 · wk-form4_1709683768.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,920 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 12,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000034 · wk-form4_1709683768.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,133 F1 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:43 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 20,006 | $33.03 | $660,798.18 |
DisclosureSEC source: 0001628908-24-000021 · wk-form4_1708983759.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,010 F3 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:43 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 44,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000021 · wk-form4_1708983759.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,016 F1 · shares: Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 22:37 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 9,020 | $35.15 | $317,053.00 |
DisclosureSEC source: 0001628908-23-000039 · wf-form4_167788304937171.xml · nonDerivative · entry 3 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,016 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:37 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 3,681 | $35.26 | $129,792.06 |
DisclosureSEC source: 0001628908-23-000039 · wf-form4_167788304937171.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,036 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:37 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 20,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-23-000039 · wf-form4_167788304937171.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,717 F1 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 00:16 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 20,025 | $28.08 | $562,302.00 |
DisclosureSEC source: 0001628908-23-000023 · wf-form4_167719779801664.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,304 F3 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PSUs. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 00:16 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 44,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-23-000023 · wf-form4_167719779801664.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,329 F1 · shares: Represents the number of shares received upon the settlement of the first tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the first tranche of the PSU award vested at the conclusion of the performance period on December 31, 2022. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 22:04 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 18,434 | $34.11 | $628,783.74 |
DisclosureSEC source: 0001628908-22-000118 · wf-form4_166086027820113.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,329 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.11 to $34.22, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2022 Filed Mar 5, 2022 01:59 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 32,344 | $27.54 | $890,753.76 |
DisclosureSEC source: 0001628908-22-000043 · wf-form4_164644552440218.xml · nonDerivative · entry 3 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,763 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of leveraged stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 01:59 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionLeveraged Restricted Stock Unit · Derivative | 71,716 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000043 · wf-form4_164644552440218.xml · derivative · entry 4 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 71,716 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Leveraged Stock Units vested on March 2, 2022. F6 · derivative.expiration_date: The Leveraged Stock Units do not expire. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 01:59 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 9,020 | $27.54 | $248,410.80 |
DisclosureSEC source: 0001628908-22-000043 · wf-form4_164644552440218.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,107 F3 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 02, 2022 Filed Mar 5, 2022 01:59 UTC | Evolent Health, Inc. EVH · Entity 5492 | Exercise / conversionClass A Common Stock | 71,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000043 · wf-form4_164644552440218.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of the leveraged stock units granted to Mr. Johnson on March 1, 2019, based on the cumulative performance of the Issuer's Class A Common Stock. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:34 UTC | Evolent Health, Inc. EVH · Entity 5492 | Tax withholdingClass A Common Stock | 4,510 | $27.40 | $123,574.00 |
DisclosureSEC source: 0001628908-22-000039 · wf-form4_164636126999318.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,411 F4 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:34 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000039 · wf-form4_164636126999318.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,921 F1 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:46 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-21-000032 · wf-form4_161482238021079.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,921 F1 · security: Includes restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 25% annually beginning March 1, 2022. F3 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:50 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-20-000034 · wf-form4_158335859172066.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,921 F1 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan. F2 · shares: Securities vest at a rate of 25% annually beginning March 2,2021. F3 · balance_after: Includes restricted stock units reported on Table 1 of Form 3 previously filed with the Securities and Exchange Commission. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.